Jeff Yass’s MediWound MDWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$267K Buy
19,400
+7,400
+62% +$103K ﹤0.01% 11244
2026
Q2
$176K Buy
+12,000
New +$191K ﹤0.01% 12066
2026
Q1
– Sell
-67,400
Closed -$1.24M – 13725
2025
Q4
$1.24M Buy
67,400
+28,000
+71% +$512K ﹤0.01% 6671
2025
Q3
$710K Sell
39,400
-39,800
-50% -$734K ﹤0.01% 8160
2025
Q2
$1.53M Buy
79,200
+67,200
+560% +$1.27M ﹤0.01% 6389
2025
Q1
$186K Buy
+12,000
New +$215K ﹤0.01% 11012
2024
Q4
– Sell
-14,700
Closed -$265K – 12812
2024
Q3
$265K Sell
14,700
-700
-5% -$12.8K ﹤0.01% 9857
2024
Q2
$239K Buy
15,400
+1,700
+12% +$28.1K ﹤0.01% 9965
2024
Q1
$195K Buy
+13,700
New +$188K ﹤0.01% 10615

Other funds holding MDWD

Jeff Yass's MDWD Position: Q3 2026 in Review

Jeff Yass sold out of MediWound (MDWD) in Q3 2026, closing a stake of 19,670 shares — an estimated $272K sold.

Jeff Yass first reported a position in MDWD in Q4 2021 and held it in 12 quarters. The position peaked at $714K in Q1 2026. 86 funds tracked by Wall St. Rank hold MDWD as of Q3 2026.

  • Jeff Yass reported no remaining MediWound position as of Q3 2026 after selling out during the quarter.
  • Jeff Yass sold 19,670 MediWound shares in Q3 2026, an estimated $272K.
  • Jeff Yass first reported a position in MediWound in Q4 2021 and held it in 12 quarters.
  • Jeff Yass's MediWound position peaked at $714K in Q1 2026.
  • 86 funds tracked by Wall St. Rank held MediWound as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.